AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

[ad_1] AstraZeneca‘s stock jumped nearly 5% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable […]

CNBC’s UK Exchange newsletter: FTSE 100’s defensive slant comes into its own

[ad_1] This report is from this week’s CNBC’s UK Exchange newsletter. Like what you see? You can subscribe here. The dispatch It was no surprise, when equity markets first reacted to news of the strikes on Iran, that the U.K.’s FTSE 100 fell by less than all of its major continental European peers. What is often seen as the Footsie’s […]